Nexus Bioquest Limited

Nexus Bioquest Limited is a small, active company based in London, UK, founded two years ago in May 2022. Employing ten people, it holds £1,806,799 in assets, though its registered address is likely a virtual one, shared by 262 other companies. The company operates under the direction of nine directors, and surprisingly, no owners are officially listed. It’s a regular importer, specializing in miscellaneous chemical products, with its last import operation recorded in February 2025.

The company describes itself as an Immunology Contract Research Organisation (CRO), focusing on providing wrap-around innovative immune research solutions to accelerate drug discovery programs. Its website highlights services including drug discovery, bespoke assay design, and therapeutic area expertise in immune oncology, autoimmunity, inflammation, and neuro-inflammation. It even has an interactive "Drug Discovery Tool" to help clients find the right assays. The company emphasizes collaboration and aims to expedite research, catering to clients seeking to leverage the immune system as a therapeutic tool or target.

Financially, Nexus Bioquest Limited presents a mixed picture. While cash reserves remain healthy at £1.4 million, net assets are negative at -£1.2 million. Creditors increased by 18% to £150,000, and trade debtors rose 11% to £170,000. Bank borrowings remain stable. Despite the negative equity, the company’s assets are substantial, and the increase in debtors could indicate growing sales. The lack of an auditor is consistent with its small size, meaning the figures are unaudited. The company’s ongoing losses, however, suggest it’s burning through cash, and the lack of listed owners could indicate a complex ownership structure.

Registered in England/Wales under the registration number 14131243, with a registered address at EC2V 6DN, United Kingdom, London, 9th Floor 107 Cheapside.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.